|
Tuesday 20th June 2023 |
Text too small? |
Auckland, New Zealand, 20 June 2023 - Fisher & Paykel Healthcare Corporation Limited attaches a copy of its presentation for the ASX’s CEO Connect webinar to be held later today.
There is no new material information contained within the presentation.
About Fisher & Paykel Healthcare
Fisher & Paykel Healthcare is a leading designer, manufacturer and marketer of products and systems for use in acute and chronic respiratory care, surgery and the treatment of obstructive sleep apnea. The company’s products are sold in over 120 countries worldwide. For more information about the company, visit our website www.fphcare.com.
Media & Investor Contacts:
Hayden Brown
Head of Capital Markets & Investor Relations
hayden.brown@fphcare.co.nz
+64 (0) 27 807 8073
Dan Adolph
Senior Communications & Investor Relations Manager
daniel.adolph@fphcare.co.nz
+64 (0) 22 511 4050
Authorised by Raelene Leonard, General Counsel and Company Secretary.
No comments yet
GEN - General Capital gives Notice of Annual Meeting 2026
AFT Chair David Flacks to retire before the next ASM
PCT - Precinct NZ $65 million Wholesale Bond Issue
FRW - Chair Announces Appointment of Successor
PCT - Future Director Appointment
FRW - Chair Announces Appointment of Successor
Me Today Market Update
IKE 1Q FY27 Performance Update
BPG - Q1 FY27 Trading Update
AFT R&D Portfolio Offers Multi-$bn Market Potential